Andrew Baum, Pfizer's chief strategy and innovation officer, talked Thursday about the pharmaceutical company's drug ...

An extraordinary rescue operation nears its end, as two children from Gaza arrive in the US for cancer treatment.

In February, health-tech startup Abridge closed a $250 million Series D round, giving the company a total reported valuation ...

Researchers at the University of Colorado's Anschutz Medical Campus have lost two scientific grants since President Donald ...

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of ...

Pfizer (PFE) stock in focus as the company sells its entire 7.3% stake in Haleon (HLN) for $3.24B. Read more here.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Pfizer Inc. invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10:00 a.m. EDT on Tuesday, April 29, 2025. The purpose of the call ...

National Institutes of Health officials have urged scientists to remove all references to mRNA vaccine technology from their ...

Eric Green, the longtime director of the National Human Genome Research Institute, has abruptly left his role, according to ...

America’s newest attorney general can thank rising Florida real estate values, a few years of lobbying and a wealthy husband for her increasing fortune.

Pfizer’s CEO Albert Bourla has revamped sales tactics, leading to a 31% rise in U.S. sales of Nurtec migraine medication, reports The Wall Street Journal.